Evidence map›Paper›PMID 32299395›Full record

ArticleBMC endocrine disorders2020

Circulating betatrophin/ANGPTL8 levels correlate with body fat distribution in individuals with normal glucose tolerance but not those with glucose disorders.

Jing Zheng, Juan Liu, Beverly S Hong, Weijian Ke, Minmin Huang, Yanbing Li

Open access · goldAbstract read
In one paragraph

Article in BMC endocrine disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Genetic and Metabolic Determinants of Plasma Levels of ANGPTL8.The Journal of clinical endocrinology and metabolism · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jing ZhengDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Juan LiuDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Beverly S HongDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Weijian KeDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Minmin HuangDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Yanbing LiDepartment of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. easd04lyb@126.com.
Sun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CN

Funding

Guangdong Key research and development program 2019B02023001National Key R&D Program of China 2018YFC1314100The Development Fund of Medical and Health Service of Guangdong Province 2109901
6 · The paper itself

Abstract

backgroundThe relationship between betatrophin/ANGPTL8 and obesity has been investigated using body mass index (BMI); however, since BMI reflects overall adiposity rather than body fat distribution, it remains unclear whether fat deposition in different areas of the body affects betatrophin expression. Here, we investigated the correlation between circulating betatrophin levels and body fat distribution in patients with different glucose tolerance.

methodsWe performed a cross-sectional study in 128 participants with impaired glucose tolerance (IGT; n = 64) or normal glucose tolerance (NGT; n = 64). Circulating betatrophin levels were detected by enzyme-linked immunosorbent assay (ELISA). Body fat distribution (subcutaneous, visceral, and limb fat) was measured by magnetic resonance imaging (MRI) and a body fat meter.

resultsAfter controlling for age, sex, and BMI, betatrophin was correlated positively with visceral adipose tissue-to-subcutaneous adipose tissue ratio (VAT/SAT ratio; r = 0.339, p = 0.009) and negatively with body fat ratio (BFR; r = - 0.275, p = 0.035), left lower limb fat ratio (LLR; r = - 0.330, p = 0.011), and right lower limb fat ratio (RLR; r = - 0.288, p = 0.027) in the NGT group, with these correlations remaining after controlling for triglycerides. VAT/SAT ratio (standardized β = 0.419, p = 0.001) was independently associated with serum betatrophin levels; however, betatrophin was not associated with body fat distribution variables in the IGT group.

conclusionsCirculating betatrophin levels correlated positively with VAT/SAT ratio and negatively with lower limb fat, but not with subcutaneous or upper limb fat, in individuals with normal glucose tolerance. Thus, betatrophin may be a potential biomarker for body fat distribution in individuals without glucose disorders.

Indexed as

Body Fat DistributionAdipose TissueAngiopoietin-Like Protein 8Angiopoietin-like ProteinsCase-Control StudiesCross-Sectional StudiesExtremitiesFemaleGlucose IntoleranceHumansIntra-Abdominal FatMagnetic Resonance ImagingMaleMiddle AgedPeptide HormonesSubcutaneous FatAngiopoietin-Like Protein 8Angiopoietin-like ProteinsANGPTL8 protein, humanPeptide HormonesBetatrophin/ANGPTL8Body fat distributionNormal glucose tolerance

Identifiers

PMID32299395
PMCPMC7161171
OpenAlexW3016853883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.